In this study we used immune sera from equine infectious anaemia virus (EIAV)-infected horses which uniquely display broad reactivity with different lentivirus capsid proteins (CA) to characterize the cross-reactive determinants of lentivirus CA proteins. In particular, the role of the major homology region (MHR) of lentivirus CA proteins in this serological cross-reactivity was evaluated using both equine immune serum and murine monoclonal antibodies (MAbs) directed against the MHR segment of different lentiviruses. The results of our studies indicate that about 80 % of sera from long-term experimentally infected ponies or naturally infected horses react with human immunodeficiency virus type 1 CA in Western immunoblot assays. In addition, the cross-reactive determinants on the EIAV CA were localized within the immunodominant carboxyl terminus of the protein (residues 277 to 367). However, the crossreactive determinants recognized by the equine sera do not appear to correlate with linear peptides from the carboxyl terminus of the EIAV CA, including the MHR. These results suggest cross-reactivity between more distant lentiviruses is associated with non-linear determinants. In contrast, MHR-specific MAbs did react with linear peptides by ELISA and distinguished the primate lentiviruses from EIAV and feline immunodeficiency virus. These data support the concept of a highly conserved structural and antigenic organization among the CA proteins of lentiviruses from different species.
In this study we used immune sera from equine infectious anaemia virus (EIAV)-infected horses which uniquely display broad reactivity with different lentivirus capsid proteins (CA) to characterize the cross-reactive determinants of lentivirus CA proteins. In particular, the role of the major homology region (MHR) of lentivirus CA proteins in this serological cross-reactivity was evaluated using both equine immune serum and murine monoclonal antibodies (MAbs) directed against the MHR segment of different lentiviruses. The results of our studies indicate that about 80 % of sera from long-term experimentally infected ponies or naturally infected horses react with human immunodeficiency virus type 1 CA in Western immunoblot assays. In addition, the cross-reactive determinants on the EIAV CA were localized within the immunodominant carboxyl terminus of the protein (residues 277 to 367). However, the crossreactive determinants recognized by the equine sera do not appear to correlate with linear peptides from the carboxyl terminus of the EIAV CA, including the MHR. These results suggest cross-reactivity between more distant lentiviruses is associated with non-linear determinants. In contrast, MHR-specific MAbs did react with linear peptides by ELISA and distinguished the primate lentiviruses from EIAV and feline immunodeficiency virus. These data support the concept of a highly conserved structural and antigenic organization among the CA proteins of lentiviruses from different species.
As in other retroviruses, the capsid protein (CA) of equine infectious anaemia virus (EIAV) is one of the most abundant proteins in the virus particle (Parekh et al., 1980; Gelderblom et al., 1987) . CA is encoded by the gag gene and is translated as part of a Gag precursor polyprotein which also includes the matrix protein (MA), the nucleocapsid protein (NC) and p9, a protein of unknown function (Montelaro et al., 1982; Henderson et al., 1987) . It is estimated that there are several thousand copies of each Gag protein within a mature virion, in contrast to only 300 copies of each envelope protein (Parekh et al., 1980) . The EIAV CA protein is highly conserved among antigenically variant virus isolates and during infection serves as one of the primary targets of the host immune response. As a result, the CA protein contains broadly reactive group-specific determinants (Dickson et al., 1982) .
During the extracellular life cycle of the virus the CA protein serves as a main structural component which forms the core shell in mature virions (Gelderblom, 1991) . In addition, the CA protein is functionally important both early after infection and later during virus budding. After infection and uncoating, it is thought that the CA stabilizes the unintegrated proviral DNA complex (Brown et al., 1987; Bowerman et al., 1989) . Late in infection, the Gag precursor is important for virus assembly and budding (Bolognesi et al., 1978) . The high degree of conservation of the CA protein sequence among different virus isolates, as well as between retroviruses in general, probably reflects intrinsic properties of the protein that are vital to virus function. In particular, it has been suggested that a 20 residue sequence within the carboxyl-terminal segment of the CA, designated the major homology region (MHR), facilitates protein interactions that result in selfassembly of the Gag precursor (Ehrlich et al., 1992; Ross et al., 1992; Strambio-De-Castillia & Hunter, 1992) . The MHR is particularly well conserved and invariant in its location within all retrovirus CA proteins (Patarca & Haseltine, 1985; Wills & Craven, 1991) .
A conserved immunogenic region within the CA protein could potentially serve as an interspecies determinant that might be exploited in diagnostic assays for the general detection of retrovirus infections. In the light of reports that sera from EIAV-infected horses display a broad serological cross-reactivity to the CA i --p24 Fig. 1 . Serological cross-reactivity to HIV-1 CA protein from ponies experimentally infected with EIAV sera 1 to 5 in lanes 1 to 5) or horses infected in the field with undefined strains of EIAV (sera 6 to 19 in lanes 6 to 19). Sucrose xadient-purified HIV-1 from chronically HIV-1 IIIB-infected H9 cells (a gift from Larry Arthur) was subjected to SDS-PAGE and the separated proteins were transferred onto nitrocellulose. Membrane strips were then probed with equine serum diluted 4000-fold, or HIV-positive patient serum followed by peroxidase-coupled species-specific antibody. The complex was detected by the ECL system (Amersham). M r markers are shown on the left, and the position of HIV CA is indicated on the right. Lane + shows reactivity of an HIV-positive patient serum to HIV-1.
protein of related lentiviruses, including human immunodeficiency virus type I (HIV-1), bovine immunodeficiency-like (BIV) and feline immunodeficiency virus (FIV) (Montagnier et al., 1981; Goudsmit et al., 1986; Whetstone et at., 1992; Atkinson et al., 1992; Steinman et al., 1990) , it has been assumed that a highly conserved region of the CA, such as the MHR, serves as an interspecies cross-reacting determinant among lentivirus CA proteins (Garvey et al., 1990) . The MHR, which is predicted to contain a B cell epitope that is exposed on infected cells (Coates et al., 1987; Ikuta et al., 1989) , is a likely candidate to serve as a target antigen in diagnostic assays. However, studies characterizing the host immune responses directed against the MHR during natural lentivirus infection have been limited, and results about the immunogenicity have been inconsistent (Schrier et al., 1989; Langedijk et al., 1990; Carpio et al., 1991; Graham et al., 1992) .
In this report, we have extended our previous analysis of the antigenicity of the EIAV CA protein (Chong et al., 1991 a) by investigating the prevalence and specificity of the EIAV serological cross-reactivity between EIAV and HIV CA proteins. Our work focuses on identification of the major interspecies cross-reactive determinants present in lentivirus CA proteins and on the humoral immune responses directed against the MHR.
To investigate the prevalence of EIAV CA-specific antibodies cross-reactive with HIV CA, we employed a reference panel of 19 EIAV-seropositive equine sera (Payne et al., 1989) . The panel of sera was obtained from either Shetland ponies experimentally infected with a cell-adapted isolate of EIAV (prototype; animals 1 to 5), or from horses naturally infected with uncharacterized field strains of EIAV (animals 6 to 19). Each of the sera, which were determined to be EIAV-positive by standard immunoassays (Shane et al., 1984) , was collected from the respective pony at least 1 year post-infection. Of the 19 EIAV-positive sera examined by Western immunoblot assay, 15 cross-reacted with the HIV CA (p24) (Fig. 1) . Thirteen of these 15 sera contained high levels of crossreactive antibodies, whereas reactivity of two sera (10 and 14) to HIV CA was barely detectable. In contrast, none of the five sera collected from EIAV-negative ponies contained antibody reactive with HIV CA (data not shown). Comparison of the prevalence of crossreactive sera in the experimentally and naturally infected animals reveals a similar 80 % positivity, indicating that the production of cross-reactive antibodies is a general The amino acid sequence and proteolytic cleavage sites are derived from Stephens et al. (1986) and Henderson et al. (1987) , respectively.
A bar (]) shows residue identity between HIV-1 and EIAV, whereas a dot (0) characteristic of long-term EIAV infection and independent of the particular virus strain.
To localize the determinant(s) in the EIAV CA inducing lentivirus cross-reactivity, a representative horse serum (Fig. 1, lane 8) with a high level of crossreactivity to HIV CA was chosen for further studies in serological blocking assays. The serum was preincubated in a 4000-fold dilution with two recombinant Escherichia coli fusion proteins (5 gg/ml) containing distinct consecutive segments of the EIAV CA (Chong et al., 1991 a) to deplete specific populations of anti-CA antibody (Fig.  2) . The remaining antibody reactivity in the adsorbed sera was then examined by Western immunoblotting against the recombinant EIAV CA protein fragments and against EIAV and HIV-1 whole virus preparations. Incubation of the serum with each fusion protein abolished the reactivity to the respective EIAV CA fragment, but did not alter reactivity to the other protein fragment (not shown), thus demonstrating the efficiency and specificity of the serum adsorptions. The fusion protein segment spanning the carboxyl-terminal 83 amino acids of the EIAV CA (the SspI-DraI fragment encoding amino acids 277 to 367) adsorbed 100 % of the reactivity to HIV CA (Fig. 3 b, lane 2) , whereas a fusion protein containing the amino-terminal fragment of the EIAV CA (BanII-Sau3AI; amino acids 121 to 246) failed to alter the serum cross-reactivity against HIV CA (Fig. 3 b, lane 3) . The reactivity of the absorbed sera in Western blots of EIAV whole virus preparations was not altered after incubation with either fusion protein (Fig.   3 a, lanes 2 and 3) . These results indicate that the crossreactive determinant(s) is located within the carboxylterminal segment of the EIAV CA protein.
As the MHR (amino acids 277 to 296; Fig. 2 ) was localized within the 83 amino acid carboxyl-terminal segment represented by the SspI-DraI fusion protein, we next investigated the contributions of EIAV MHRspecific antibody to the overall cross-reactivity between EIAV and HIV CA by depleting the reference equine serum of EIAV MHR-specific antibody prior to assaying for cross-reactivity. Initially a synthetic peptide homologue of the EIAV MHR region ( Fig. 2 ; amino acids 277 to 298) was synthesized and used to prepare a Sepharose 4B affinity column. Following several passes of serum from horse 8 through the column to remove MHR-specific antibody, the serum preparation exhibited no reactivity against the EIAV MHR peptide in ELISA (data not shown), yet still contained significant serological cross-reactivity with HIV CA in a Western immunoblot assay (Fig. 3 b, lane 4) . These data suggest strongly that the MHR of the EIAV CA alone does not serve as an interspecies cross-reactive determinant.
To examine further the carboxyl-terminal segment of EIAV CA for the presence of lentivirus cross-reactive determinants, synthetic peptides corresponding to amino acids 294 to 325 and amino acids 326 to 352 were synthesized and used in serological blocking assays as follows (Fig. 2) . Peptides (60 ~tg) were added to 1 ml of horse serum 8 (diluted 200-fold) and incubated at room temperature overnight. Each peptide adsorption corn- . Reactivity of EIAV-specific antibodies to HIV and EIAV CA proteins after absorption with trpLE-Gag fusion proteins or blocking with CA-specific synthetic peptides. Serum from horse 8 was incubated overnight at room temperature with EIAV CA fusion proteins expressed in E. coli (Chong et al., 1991 a) . Depleting horse serum 8 for peptide-specific antibodies was carried out either by peptide affinity column purification (peptide amino acids 277 to 298) or by blocking reactivity of the serum after incubation with the peptide overnight.
Residual reactivity was determined in Western immunoblots as described in Fig. 1 pletely removed antibody reactivity to the respective peptide, but none of the peptide adsorptions significantly reduced the pony serum reactivity to the HIV CA protein (Fig. 3 , lanes 5 and 6 respectively). These observations indicate that the CA cross-reactivity does not map to linear peptide sequences encompassing the carboxylterminal segments of the CA protein, but most likely is correlated with non-linear or conformational determinants in this portion of the protein molecule. In contrast to the findings described above, previous studies using MAbs suggested that the M H R constitutes a linear group-specific determinant for primate immunodeficiency viruses (Niedrig et al., 1991; Matsuo et al., 1992) . To investigate whether our inability to identify a linear cross-reactive determinant within the EIAV CA reflects differences in cross-reactivity between diverse lentiviruses or species-specific differences in specificity of antibody responses, we examined MAbs specific for the M H R regions of EIAV, HIV-2 and simian immunodeficiency virus macaque strain (SIVmae) for their relative ability to recognize peptide homologues of the M H R region of primate lentiviruses (HIV-1, SIVtyo, SIV ...... ) and non-primate lentiviruses (EIAV and FIV) by ELISA (Fig. 4) . Both of the HIV-2-specific MAbs (88-178/023, 88-178/129) reacted with each of the primate lentivirus M H R peptides, but did not recognize the non-primate M H R peptide homologues. Similarly, the two S[Vma e MHR-specific MAbs (SP8C10 and SB6D2) reacted with all primate lentivirus M H R peptides, but with none of the other M H R peptides. Alternatively, the EIAV MHRspecific MAb (141) reacted with the EIAV-MHR peptide homologue, but did not recognize any of the other M H R peptides tested. These data demonstrate that the M H R of lentivirus CA proteins does indeed represent a linear interspecies cross-reacting determinant, but that this cross-reactivity is confined to the primate lentiviruses. This conclusion is supported by the observation that of the 15 pony sera cross-reactive against HIV-1 CA, none of them recognize M H R peptide homologues of the primate lentivirus as measured directly by peptide ELISA (data not shown).
The primary goal of this study was to define determinants within the EIAV CA that elicit crossreactive antibodies to HIV CA and to examine specifically whether the M H R functions as an interspecies cross-reactive determinant as suggested by its sequence homology with other retrovirus CA proteins. Sera from 19 long-term EIAV-infected ponies or horses displayed a high prevalence of cross-reactivity to HIV CA (Fig. 1) . The reactive cross-reactive site(s) were localized within the carboxyl-terminal segment of the EIAV CA as the cross-reactivity was completely abolished by absorption of horse sera with a recombinant fusion protein representing the terminal 83 residues of EIAV CA. However, horse antibodies specific for synthetic peptide homologues derived from the carboxyl-terminal EIAV CA fragment were not cross-reactive to HIV CA.
Nevertheless, for the primate immunodeficiency viruses, including HIV-2, HIV-1, SIVma o and SIV~gm, the M H R segment within the carboxyl-terminal domain of their respective CA proteins has been established as a cross-reactive site as previously suggested (Niedrig et al., 1991; Matsuo et al., 1992) . Studying the cross-reactivity between distinct members of the lentivirus subgroup, such as EIAV and HIV, we could not identify the site of cross-reactivity by using a panel of synthetic peptides, suggesting that cross-reactive antibodies are directed towards non-linear sites in the EIAV CA protein.
Although it is conceivable that a more extensive panel of overlapping peptides might reveal a cross-reactive linear determinant, this possibility seems unlikely in light of the lack of significant amino acid sequence homology Plates were incubated with horse sera diluted 50-fold, followed by incubation with peroxidase-labelled anti-horse Ig antibodies. Colour reaction of the substrate o-phenylenediamine dihydrochloride was read at 490 nm after a 1 h development at room temperature. Reactivities of the MAbs to the MHR peptide homologues are represented by bars. The MAb reactivity is normalized by expressing absorbance as a percentage of the maximum reading for each MAb reacting with a specific peptide. HIV-2-specific MAbs were a gift from M. Niedrig and are described elsewhere (Niedrig et al., 1991) .
between EIAV and HIV-1 outside of the MHR segment of the respective CA proteins. Rather it appears more likely that the lentivirus cross-reactive determinants recognized during persistent EIAV infections in horses is correlated with non-linear or conformation-dependent antigenic determinants. In this regard it is interesting to note a recent study by Haist et al. (1993) reporting that at least 50 % of the HIV-1 CA-specific antibodies in patients' sera are directed to conformationally dependent determinants. We have previously proposed that homologous proteins of retroviruses should possess similar structural properties to fulfil critical biological functions common to all retroviruses and that these common structural motifs can be formed by variant combinations of amino acid sequences (Ball et al., 1992) . In earlier studies, we noted the similarities in the antigenic architecture of the envelope (SU and TM) and CA proteins of EIAV compared to the homologous proteins of HIV-1 (Bail et al., 1992; Chong et al., 1991a, b; Gallaher et al., 1989) . Additional studies aimed at identifying conserved structural and functional motifs in retrovirus proteins will provide the foundation for developing diagnostic and antiviral targets that minimize the dependence on conservation of primary amino acid sequence.
